{"id":63102,"date":"2023-02-14T16:27:11","date_gmt":"2023-02-14T21:27:11","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=63102"},"modified":"2023-06-06T18:23:57","modified_gmt":"2023-06-06T22:23:57","slug":"jensen-lab-receives-nhlbi-funding-renewal","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/jensen-lab-receives-nhlbi-funding-renewal\/","title":{"rendered":"Jensen Lab Receives NHLBI Funding Renewal"},"content":{"rendered":"
The Jensen Lab is run by Brian Jensen, MD<\/a>, associate professor of medicine and pharmacology. Co-investigators on the award are Kelsey Fisher-Wellman and Jessica Ellis from East Carolina University.<\/p>\n Read more about the Jensen Lab.\u00a0<\/a><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" The National Heart, Lung and Blood Institute renewed\u00a0the Jensen Lab’s R01 funding for 5-years at $2.48 million for its project, \u201cMetabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation.\u201d The grant will support ongoing investigation of the adaptive effects of alpha-1A adrenergic receptors on mitochondrial function in the heart. The proposed work also will seek … Read more<\/a><\/p>\n","protected":false},"author":112673,"featured_media":3728,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[86,2],"tags":[632],"class_list":["post-63102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology","category-news","tag-632","odd"],"acf":[],"yoast_head":"\n<\/a>The National Heart, Lung and Blood Institute renewed\u00a0the Jensen Lab’s R01 funding for 5-years at $2.48 million for its project, \u201cMetabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation.\u201d The grant will support ongoing investigation of the adaptive effects of alpha-1A adrenergic receptors on mitochondrial function in the heart. The proposed work also will seek to define whether antagonists of alpha-1A adrenergic receptors, commonly used to treat prostate disorders, adversely affect cardiometabolic risk.<\/p>\n